Biologics Contract Development & Manufacturing
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,026
NCT03180242
A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 22, 2016
Completion: Aug 22, 2016
NCT03433313
Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer
Phase: Phase 3
Start: Oct 16, 2018
Completion: Jan 20, 2022
NCT05471648
A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers
Start: May 16, 2022
Completion: Jan 24, 2023
NCT06884254
Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer.
Start: May 31, 2025
Completion: Dec 31, 2027
Loading map...